Liquid-liquid phase separation of tau regulates client binding via a conformational relay

This study demonstrates that liquid-liquid phase separation of the intrinsically disordered tau protein induces electrostatic compaction and transient oligomerization that selectively enhance binding to the chaperone BRICHOS, enabling it to compete with tubulin and thereby regulate microtubule assembly through a conformational relay mechanism.

The Gist

Imagine your brain is a bustling city, and the protein Tau is a construction worker. Normally, Tau's job is to hold together the city's roads (called microtubules) by grabbing onto the pavement (tubulin) and keeping everything stable.

But sometimes, Tau gets confused. Instead of holding the roads, it starts clumping together into giant, sticky blobs called condensates (or "liquid-liquid phase separation"). Think of this like a construction crew suddenly deciding to huddle together in a giant, gooey ball in the middle of the street. While they are in this ball, they stop fixing the roads, and if they stay there too long, they can turn into hard, permanent knots that damage the city (which is what happens in Alzheimer's disease).

This paper is about a "traffic cop" named BRICHOS (a chaperone protein) and how it interacts with Tau when Tau gets stuck in these gooey balls.

Here is the story of what the scientists discovered, broken down into simple concepts:

1. The "Salt" Switch

The scientists found that the environment controls Tau's behavior.

• High Salt (Normal City): When there is a lot of salt (like in a normal cell), Tau is loose and spread out. It's like a construction worker walking freely, ready to fix roads.
• Low Salt (The Gooey Ball): When the salt is low, Tau gets "electrostatically charged" and starts hugging itself and its neighbors. It shrinks down, gets compact, and forms those sticky liquid droplets.

2. The Traffic Cop Arrives

The researchers introduced BRICHOS, a protein that acts like a specialized traffic cop designed to stop Tau from turning into a permanent knot.

• The Surprise: They found that BRICHOS only grabs onto Tau when Tau is in that "gooey ball" (condensate) state. When Tau is walking freely (high salt), BRICHOS ignores it.
• The "Key and Lock" Moment: Inside the gooey ball, Tau changes its shape slightly. It exposes a specific "handle" (a specific section of its body) that BRICHOS can grab onto. It's like Tau puts on a special hat only when it's in the crowd, and BRICHOS is the only one who knows how to grab that hat.

3. The Great Competition

Here is the most important part of the story.

• The Problem: When Tau is in the gooey ball, it usually grabs onto Tubulin (the road material) to start building roads. This is good for the city, but if it goes on too long, it can lead to the bad knots.
• The Intervention: When BRICHOS arrives, it grabs that same "handle" on Tau. Because BRICHOS is holding onto Tau, Tau can no longer hold onto the road material (Tubulin).
• The Result: It's a game of musical chairs. BRICHOS sits in the chair (Tau's binding site), so Tubulin can't sit there.
  • Without BRICHOS: Tau grabs Tubulin, and the roads start building (sometimes too fast or in the wrong way).
  • With BRICHOS: Tau is distracted by the traffic cop. The road building stops, and the gooey ball stays liquid instead of turning into a hard, damaging knot.

4. The "Electrostatic Relay"

The scientists call this an "electrostatic relay." Think of it like a switchboard.

1. Low Salt flips the switch, making Tau shrink and clump.
2. This shrinking exposes the secret handle.
3. BRICHOS sees the handle and grabs it.
4. Because BRICHOS is holding Tau, Tubulin is blocked from doing its job.

Why Does This Matter?

This is a big deal for understanding diseases like Alzheimer's.

• The Bad News: If Tau gets stuck in these gooey balls and turns into hard knots, it kills brain cells.
• The Good News: This study shows that the cell has a built-in safety mechanism (BRICHOS). When Tau gets too crowded, BRICHOS steps in, grabs it, and stops it from building the wrong things.
• The Future: By understanding exactly how and when BRICHOS grabs Tau, scientists might be able to design drugs that mimic this behavior. We could create a "super-traffic cop" that stops Tau from turning into those dangerous knots, keeping the brain's roads clear and safe.

In a nutshell:
Tau is a construction worker who sometimes gets stuck in a sticky crowd. A special helper (BRICHOS) waits for that crowd to form, then grabs the worker to stop them from building dangerous structures. The scientists figured out the exact handshake that makes this happen, giving us a new blueprint for how to protect the brain.

Technical Summary

1. Problem Statement

Intrinsically disordered proteins (IDPs) like tau regulate cellular functions through dynamic, multivalent interactions that often drive Liquid-Liquid Phase Separation (LLPS). While LLPS creates concentrated, membraneless condensates, a fundamental gap exists in understanding how the transition from a dispersed state to a condensed state reshapes the conformational landscape of IDPs and alters their binding preferences. Specifically, it is unclear how LLPS regulates the competition between functional partners (e.g., tubulin for microtubule assembly) and regulatory modulators (e.g., chaperones) within these dense phases. The transient and multivalent nature of these interactions makes them experimentally difficult to characterize.

2. Methodology

The authors employed a multi-modal, integrated experimental and computational strategy to dissect tau interactions under conditions that promote both dispersed and condensed states:

• Native Ion Mobility Mass Spectrometry (IM-MS): Used to analyze the charge-state distributions and collision cross-sections (CCS) of tau ions. This allowed the authors to monitor conformational compaction and oligomeric states in the gas phase while preserving solution-like features.
• Mass Photometry (MP): Used at nanomolar concentrations to detect transient oligomerization and protein-protein complexes (tau-tubulin, tau-BRICHOS) without inducing macroscopic phase separation, providing stoichiometric data.
• Fluorescence Microscopy: Utilized to visualize tau condensates (droplets) and assess the co-localization of client proteins (tubulin, BRICHOS) and the morphological changes (e.g., microtubule growth vs. aggregation) over time.
• Computational Modeling:
  • AlphaFold2 & AlphaFold3: Used to predict binding interfaces between tau peptides and BRICHOS/tubulin, and to model ternary complexes to assess binding exclusivity.
  • Molecular Dynamics (MD) Simulations: Conducted to understand the salt-dependent conformational shifts of tau peptides and the electrostatic mechanisms driving binding.
• Experimental Conditions: Experiments were performed by varying ammonium acetate (AmAc) concentrations (from 100 mM to 2.5 mM) to modulate ionic strength, thereby controlling the transition from a dispersed state to an LLPS-promoting state.

3. Key Contributions

• Conformational Relay Mechanism: The study establishes that LLPS-promoting conditions (low salt) induce an electrostatically driven compaction of tau, shifting its conformational ensemble toward more compact monomers and transient oligomers.
• Condition-Dependent Binding: The authors demonstrate that the binding of the chaperone BRICHOS (from the Bri2 protein) to tau is strictly dependent on the LLPS-promoting conformational state of tau, specifically targeting the proline-rich region (PRR).
• Competitive Inhibition Model: The paper provides a mechanistic model showing that BRICHOS and tubulin compete for adjacent but mutually exclusive binding sites on tau. BRICHOS binding to the PRR blocks tubulin access to the microtubule-binding repeats (MTBR).
• Generalizable Framework: The authors present a proof-of-concept workflow combining native MS, MP, and modeling to detect conformational selectivity and client binding preferences within dynamic condensates, applicable to other IDP systems.

4. Key Results

• LLPS Induces Tau Compaction:

  • Lowering AmAc concentration from 100 mM to 2.5 mM triggered tau LLPS (visible as droplets).
  • IM-MS revealed a progressive reduction in the average charge state and arrival time of tau ions at low salt, indicating a more compact conformational ensemble driven by intramolecular electrostatic interactions.
  • MP showed that at intermediate salt concentrations, tau forms transient dimers and trimers, while at very low salt, it exists as compact monomers or polydisperse clusters prior to macroscopic condensation.

• Selective BRICHOS Binding:

  • Native MS showed no interaction between tau and BRICHOS at high salt (100 mM), but a distinct 1:1 complex formed at low salt (2.5 mM).
  • AlphaFold2 and MD simulations identified the binding site as residues 217–235 within the proline-rich region (PRR). The binding is driven by salt-bridge formation between tau's acidic residues and BRICHOS's basic residues, facilitated by the reduced charge screening in low-salt conditions.
  • Specificity was confirmed: BRICHOS from proSP-C did not bind tau, indicating the interaction is specific to the Bri2 BRICHOS domain.

• Competition with Tubulin:

  • Microscopy: In the presence of GTP, tau droplets normally recruit tubulin and grow microtubule fibrils. However, adding BRICHOS prevented fibril formation, resulting in non-fibrillar aggregates.
  • MP & Modeling: Under LLPS conditions, tau and tubulin form higher-order oligomers (complexes). The addition of BRICHOS abolished these complexes, leaving only monomeric species.
  • AlphaFold3 predictions of ternary complexes (Tau + Tubulin + BRICHOS) showed that while tubulin binds the MTBR and BRICHOS binds the adjacent PRR, they cannot bind simultaneously. The binding of BRICHOS to the PRR sterically or allosterically prevents tubulin engagement.

5. Significance

• Mechanistic Insight into Neurodegeneration: The findings suggest a regulatory "relay" where LLPS not only concentrates tau but also alters its conformation to favor chaperone binding over cytoskeletal assembly. This provides a potential mechanism for how cells regulate tau function and prevent pathological aggregation.
• Therapeutic Implications: The study identifies specific, disease-relevant binding interfaces (e.g., residues 223–231) that are exposed or stabilized only under specific conformational states. This offers new targets for therapeutics aimed at modulating tau-chaperone interactions to prevent amyloid formation or restore microtubule stability.
• Methodological Advancement: The work validates a robust strategy for studying transient, multivalent interactions in IDPs that are otherwise invisible to traditional structural biology methods, bridging the gap between solution-phase dynamics and condensed-phase biology.